

Celsion is a biopharmaceutical company which develops innovative, targeted therapies that address unmet medical needs in oncology. Among its major competitors, Celsion is ranked in 6th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $13.91M